RPRX — Royalty Pharma
Median target
$66
calls from the last 12 months
Implied return
-0.6%
median target vs. price
Coverage
7 analysts · 8 calls
updated in the last 12 months
Consensus
7/0/0+7 net
Buy / Hold / Sell
Which analysts are behind RPRX's consensus?
See every current rating, price target and the analysts' track records for Royalty Pharma — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 7 analysts with calls on RPRX updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
RPRX elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-10-05 | Insiders | Urist MarshallEVP, Research & Investme | Insider sale | 4.1K sh @ $57.10 · planned trade | $236K |
| 2026-09-28 | Insiders | Urist MarshallOfficer | Insider sale | 4.1K sh @ $57.88 · planned trade | $239K |
| 2026-09-22 | Insiders | Hite ChristopherOfficer | Insider sale | 96.1K sh @ $58.51 · planned trade | $5.6M |
| 2026-09-22 | Insiders | Hite ChristopherOfficer | Insider sale | 3.9K sh @ $58.93 · planned trade | $231K |
| 2026-04-07 | Executive | Trump, Donald JPresident | Sale | Royalty Pharma plc | $1,001 - $15,000 |
| 2025-10-15 | Executive | Trump, Donald JPresident | Purchase | ROYALTY PHARMA PLC CL A | $1,001 - $15,000 |
| 2025-04-28 | Executive | Landau, ChristopherDeputy Secretary | Sale | Royalty Pharma plc Class A Ordinary Shares (RPRX) | $100,001 - $250,000 |
| 2025-04-17 | Executive | Trump, Donald JPresident | Purchase | ROYALTY PHARMA PLC CL A | $1,001 - $15,000 |
| 2025-04-04 | Executive | Trump, Donald JPresident | Sale | Royalty Pharma plc | $1,001 - $150,004 |
| 2025-04-03 | Executive | Trump, Donald JPresident | Purchase | Royalty Pharma plc | $1,001 - $150,004 |
More: insider activity · executive branch · trending